Ninety-day postoperative mortality is a legitimate measure of hepatopancreatobiliary surgical quality

Annals of Surgery

Volumn 262, Issue 6, 2015, Pages 1071-1078

  Mise, Yoshihiro ^a   Vauthey, Jean Nicolas ^a   Zimmitti, Giuseppe ^a   Parker, Nathan H ^a   Conrad, Claudius ^a   Aloia, Thomas A ^a   Lee, Jeffrey E ^a   Fleming, Jason B ^a   Katz, Matthew Harold G ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Hepatectomy; Mortality; Pancreatectomy; Postoperative complications; Root cause analysis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CAUSE OF DEATH; CHILD; FEMALE; HEALTH CARE QUALITY; HOSPITALIZATION; HUMAN; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PANCREAS RESECTION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; ROOT CAUSE ANALYSIS; SURGICAL MORTALITY; EVALUATION STUDY; HOSPITAL MORTALITY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; STANDARDS; STATISTICS AND NUMERICAL DATA; TEXAS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATECTOMY; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PANCREATECTOMY; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; QUALITY INDICATORS, HEALTH CARE; RETROSPECTIVE STUDIES; TEXAS; YOUNG ADULT;

EID: 84948718113     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000001048     Document Type: Article

References (51)

1. Strasberg SM, Linehan DC, Hawkins WG. The accordion severity grading system of surgical complications. Ann Surg. 2009;250:177-186.
2. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-213.
3. Bilimoria KY, Bentrem DJ, Lillemoe KD, et al. Assessment of pancreatic cancer care in the United States based on formally developed quality indicators. J Natl Cancer Inst. 2009;101:848-859.
4. Damhuis RA, Wijnhoven BP, Plaisier PW, et al. Comparison of 30-day, 90-day and in-hospital postoperative mortality for eight different cancer types. Br J Surg. 2012;99:1149-1154.
5. Russell EM, Bruce J, Krukowski ZH. Systematic review of the quality of surgical mortality monitoring. Br J Surg. 2003;90:527-532.
6. Khuri SF, Daley J, Henderson W, et al. The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement Program. Ann Surg. 1998;228:491-507.
7. Johnson ML, Gordon HS, Petersen NJ, et al. Effect of definition of mortality on hospital profiles. Med Care. 2002;40:7-16.
8. Shirabe K, Shimada M, Gion T, et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg. 1999;188: 304-309.
9. Tanabe G, Sakamoto M, Akazawa K, et al. Intraoperative risk factors associated with hepatic resection. Br J Surg. 1995;82:1262-1265.
10. Adham M, Chopin-Laly X, Lepilliez V, et al. Pancreatic resection: drain or no drain? Surgery. 2013;154:1069-1077.
11. Brouquet A, Abdalla EK, Kopetz S, et al. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol. 2011;29:1083-1090.
12. Dokmak S, Fteriche FS, Borscheid R, et al. 2012 Liver resections in the 21st century: we are far from zero mortality. HPB (Oxford). 2013;15: 908-915.
13. Gold JS, Are C, Kornprat P, et al. Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients. Ann Surg. 2008;247:109-117.
14. Lewis R, Drebin JA, Callery MP, et al. A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma. HPB (Oxford). 2013;15:49-60.
15. Mullen JT, Ribero D, Reddy SK, et al. Hepatic insufficiency and mortality in 1, 059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg. 2007;204:854-862; discussion 862-864.
16. Reddy SK, Barbas AS, Turley RS, et al. A standard definition of major hepatectomy: resection of four or more liver segments. HPB (Oxford). 2011;13:494-502.
17. Shindoh J, Vauthey JN, Zimmitti G, et al. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach. J Am Coll Surg. 2013;217:126-133; discussion 133-134.
18. Torzilli G, Belghiti J, Kokudo N, et al. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations? An observational study of the HCC East-West study group. Ann Surg. 2013;257:929-937.
19. Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006;24:2065-2072.
20. Hartwig W, Gluth A, Hinz U, et al. Total pancreatectomy for primary pancreatic neoplasms: renaissance of an unpopular operation. Ann Surg. 2015;261:537-546.
21. Voron T, Tselikas L, Pietrasz D, et al. Sarcopenia impacts on short-and long-term results of hepatectomy for hepatocellular carcinoma. Ann Surg. 2015;261:1173-1183.
22. Hwang RF, Wang H, Lara A, et al. Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer. Ann Surg Oncol. 2008;15:1356-1366.
23. Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149:713-724.
24. Koch M, Garden OJ, Padbury R, et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery. 2011;149:680-688.
25. Wente MN, Veit JA, Bassi C, et al. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery. 2007;142:20-25.
26. Belghiti J, Hiramatsu K, Benoist S, et al. Seven hundred forty-seven hep-atectomies in the 1990 s: an update to evaluate the actual risk of liver resection. J Am Coll Surg. 2000;191:38-46.
27. Finks JF, Osborne NH, Birkmeyer JD. Trends in hospital volume and operative mortality for high-risk surgery. N Engl J Med. 2011;364:2128-2137.
28. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309-318; discussion 318-321.
29. Imamura H, Seyama Y, Kokudo N, et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg. 2003;138:1198-1206; discussion 1206.
30. Sosa JA, Bowman HM, Gordon TA, et al. Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg. 1998;228:429-438.
31. Torzilli G, Makuuchi M, Inoue K, et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg. 1999;134:984-992.
32. Perkins NJ, Schisterman EF. The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006;163:670-675.
33. Niro GA, Casey JL, Gravinese E, et al. Intrafamilial transmission of hepatitis delta virus: molecular evidence. J Hepatol. 1999;30:564-569.
34. Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32-35.
35. Nagino M, Kamiya J, Uesaka K, et al. Complications of hepatectomy for hilar cholangiocarcinoma. World J Surg. 2001;25:1277-1283.
36. Takeda K, Togo S, Kunihiro O, et al. Clinicohistological features of liver failure after excessive hepatectomy. Hepatogastroenterology. 2002;49:354-358.
37. Tzeng CW, Tran Cao HS, Lee JE, et al. Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival. J Gastrointest Surg. 2014;18:16-25.
38. Vollmer CM Jr, Sanchez N, Gondek S, et al. A root-cause analysis of mortality following major pancreatectomy. J Gastrointest Surg. 2012;16:89-102; discussion 102-103.
39. Hsu CC, Wolfgang CL, Laheru DA, et al. Early mortality risk score: identification of poor outcomes following upfront surgery for resectable pancreatic cancer. J Gastrointest Surg. 2012;16:753-761.
40. Baumgartner JM, Krasinskas A, Daouadi M, et al. Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic adenocarcinoma following neoadjuvant therapy. J Gastrointest Surg. 2012;16:1152-1159.
41. Mayo SC, Shore AD, Nathan H, et al. Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion. HPB (Oxford). 2011;13:473-482.
42. Carroll JE, Smith JK, Simons JP, et al. Redefining mortality after pancreatic cancer resection. J Gastrointest Surg. 2010;14:1701-1708.
43. Choti MA, Bowman HM, Pitt HA, et al. Should hepatic resections be performed at high-volume referral centers? J Gastrointest Surg. 1998;2:11-20.
44. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346:1128-1137.
45. Fong Y, Gonen M, Rubin D, et al. Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg. 2005;242:540-544; discussion 544-547.
46. Csikesz NG, Simons JP, Tseng JF, Shah SA. Surgical specialization and operative mortality in hepato-pancreatico-biliary (HPB) surgery. J Gastro-intest Surg. 2008;12:1534-1539.
47. McKay A, You I, Bigam D, et al. Impact of surgeon training on outcomes after resective hepatic surgery. Ann Surg Oncol. 2008;15:1348-1355.
48. Katz MH, Wang H, Fleming JB, et al. Long-term survival after multidiscipli-nary management of resected pancreatic adenocarcinoma. Ann Surg Oncol. 2009;16:836-847.
49. de Wilde RF, Besselink MG, van der Tweel I, et al. Impact of nationwide centralization of pancreaticoduodenectomy on hospital mortality. Br J Surg. 2012;99:404-410.
50. McPhee JT, Hill JS, Whalen GF, et al. Perioperative mortality for pancrea-tectomy: a national perspective. Ann Surg. 2007;246:246-253.
51. Tzeng CW, Fleming JB, Lee JE, et al. Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy. HPB (Oxford). 2012;14:365-372.